Meijer Multi-Symptom Relief
- Manufacturer
- K.C. Pharmaceuticals, Inc.
- Effective date
- 2023-01-06
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:41:24
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
DRUG FACTS
Active ingredients
Polyethylene glycol 400 ........1%
Tetrahydrozoline HCl.............0.05%
Zinc sulfate............................0.25%
OTC - PURPOSE SECTION
Purposes
Polyethylene glycol 400 .....Lubricant
Tetrahydrozoline HCl...........Redness reliever
Zinc sulfate..........................Astringent
INDICATIONS & USAGE SECTION
Uses
- relieves dryness of the eye
- for temporary relief of discomfort and redness of the eye due to minor eye irritations
- for temporary relief of burning and irritation due to exposure to wind or sun
- for protection against further irritation
WARNINGS SECTION
Warnings
For external use only
OTC - ASK DOCTOR SECTION
Ask a doctor before use if you have narrow angle glaucoma
OTC - WHEN USING SECTION
When using this product
- pupils may become enlarged temporarily
- overuse may cause more eye redness
- remove contact lenses before using
- do not touch tip of container to any surface to avoid contamination
- replace cap after using
- do not use if this solution changes color or becomes cloudy
OTC - ASK DOCTOR SECTION
Stop use and ask a doctor if
- you feel eye pain
- changes in vision occur
- redness or irritation of the eye lasts
- condition worsens or lasts more than 72 hours
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
DOSAGE & ADMINISTRATION SECTION
Directions
- Instill 1 to 2 drops in the affected eye(s) up to 4 times daily
- children under 6 years of age: ask a doctor
OTHER SAFETY INFORMATION
Other information
- some users may experience a brief tingling sensation
- store at 20-25°C (68-77ºF)
INACTIVE INGREDIENT SECTION
Inactive ingredients
benzalkonium chloride, boric acid, edetate disodium, glycerin, hypromellose, purified water, sodium chloride, sodium citrate
OTC - QUESTIONS SECTION
Questions or comments?
Call 1-888-527-4276
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Products#
Every source-derived product name is available through these pages.
- Meijer Multi-Symptom Relief
- polyethylene glycol, tetrahydrozoline hydrochloride, zinc sulfate
- TETRAHYDROZOLINE HYDROCHLORIDE
- TETRAHYDROZOLINE
- POLYETHYLENE GLYCOL 400
- ZINC SULFATE
- ZINC CATION
- WATER
- SODIUM CITRATE
- BORIC ACID
- GLYCERIN
- BENZALKONIUM CHLORIDE
- EDETATE DISODIUM
- HYPROMELLOSES
- SODIUM CHLORIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 55651-250 | 55651-250-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| TETRAHYDROZOLINE HYDROCHLORIDE | 0YZT43HS7D | ACTIB |
| POLYETHYLENE GLYCOL 400 | B697894SGQ | ACTIB |
| ZINC SULFATE | 89DS0H96TB | ACTIB |
| WATER | 059QF0KO0R | IACT |
| SODIUM CITRATE | 1Q73Q2JULR | IACT |
| BORIC ACID | R57ZHV85D4 | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | IACT |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| HYPROMELLOSES | 3NXW29V3WO | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f1a2bfe5-ef9f-92b7-e053-2995a90a4aa3 | f1a2bfe5-ef9e-92b7-e053-2995a90a4aa3 | 2023-01-06 | Warnings | f1a2bfe5-ef9f-92b7-e053-2995a90a4aa3 f1a2bfe5-ef9e-92b7-e053-2995a90a4aa3 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
